Royal Bank of Canada’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.18M | Buy |
223,208
+220,746
| +8,966% | +$6.11M | ﹤0.01% | 2189 |
|
|
2025
Q1 | $55K | Buy |
2,462
+568
| +30% | +$12.7K | ﹤0.01% | 5161 |
|
|
2024
Q4 | $38K | Sell |
1,894
-3,277
| -63% | -$65.7K | ﹤0.01% | 5336 |
|
|
2024
Q3 | $129K | Buy |
5,171
+551
| +12% | +$13.7K | ﹤0.01% | 4726 |
|
|
2024
Q2 | $87K | Buy |
4,620
+2,793
| +153% | +$52.6K | ﹤0.01% | 4966 |
|
|
2024
Q1 | $36K | Sell |
1,827
-9,761
| -84% | -$192K | ﹤0.01% | 5229 |
|
|
2023
Q4 | $203K | Buy |
11,588
+4,535
| +64% | +$79.4K | ﹤0.01% | 4568 |
|
|
2023
Q3 | $123K | Buy |
7,053
+3,530
| +100% | +$61.6K | ﹤0.01% | 4764 |
|
|
2023
Q2 | $50K | Buy |
3,523
+1,080
| +44% | +$15.3K | ﹤0.01% | 5334 |
|
|
2023
Q1 | $27K | Sell |
2,443
-2,263
| -48% | -$25K | ﹤0.01% | 5526 |
|
|
2022
Q4 | $71K | Buy |
4,706
+4,072
| +642% | +$61.4K | ﹤0.01% | 5227 |
|
|
2022
Q3 | $8K | Buy |
634
+208
| +49% | +$2.63K | ﹤0.01% | 6043 |
|
|
2022
Q2 | $4K | Sell |
426
-1,615
| -79% | -$15.2K | ﹤0.01% | 6260 |
|
|
2022
Q1 | $20K | Sell |
2,041
-4,582
| -69% | -$44.9K | ﹤0.01% | 6120 |
|
|
2021
Q4 | $78K | Buy |
6,623
+3,673
| +125% | +$43.3K | ﹤0.01% | 5576 |
|
|
2021
Q3 | $34K | Buy |
2,950
+704
| +31% | +$8.11K | ﹤0.01% | 5861 |
|
|
2021
Q2 | $31K | Sell |
2,246
-1,255
| -36% | -$17.3K | ﹤0.01% | 5823 |
|
|
2021
Q1 | $64K | Buy |
3,501
+1,470
| +72% | +$26.9K | ﹤0.01% | 5245 |
|
|
2020
Q4 | $35K | Buy |
2,031
+864
| +74% | +$14.9K | ﹤0.01% | 5259 |
|
|
2020
Q3 | $18K | Buy |
1,167
+1,025
| +722% | +$15.8K | ﹤0.01% | 5244 |
|
|
2020
Q2 | $3K | Buy |
142
+94
| +196% | +$1.99K | ﹤0.01% | 5704 |
|
|
2020
Q1 | $1K | Sell |
48
-1,148
| -96% | -$23.9K | ﹤0.01% | 5942 |
|
|
2019
Q4 | $13K | Buy |
+1,196
| New | +$13K | ﹤0.01% | 5446 |
|
|
2019
Q1 | – | Sell |
-145
| Closed | -$4K | – | 5831 |
|
|
2018
Q4 | $4K | Sell |
145
-85
| -37% | -$2.35K | ﹤0.01% | 5365 |
|
|
2018
Q3 | $6K | Buy |
+230
| New | +$6K | ﹤0.01% | 5577 |
|